NRX Pharmaceuticals
NRXP
NRXP
30 hedge funds and large institutions have $3.04M invested in NRX Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
19% less funds holding
Funds holding: 37 → 30 (-7)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Holders
30
Holding in Top 10
–
Calls
$274K
Puts
$53K
Top Buyers
| 1 | +$591K | |
| 2 | +$233K | |
| 3 | +$42.7K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$9.21K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.22K |
Top Sellers
| 1 | -$178K | |
| 2 | -$120K | |
| 3 | -$61.8K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$40K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$30K |